OKLAHOMA CITY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Devon Energy Corp. (NYSE: DVN) announced today that Brent J. Smolik has joined its Board of Directors effective Oct. 1. Mr. Smolik is the former president and chief operating officer of Noble Energy and president, CEO and chairman of the board of EP Energy Corporation. “We are pleased to welcome Brent Smolik to our Board of Directors,” said Clay Gaspar, president and CEO. “His leadership and strategic insight will be instrumental as we continue to deliver val ...

Subsea 7 S.A. has received notification of transactions in its shares by primary insiders. Please see the attachment for details. This information is pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act. Attachment SUBC 2025 LTIP Trade Notifications ...

NEW YORK AND ATLANTA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Brookfield and Angel Oak Companies (“Angel Oak”), a leading asset manager specializing in innovative mortgage and consumer products, today announced the closing of their strategic partnership. Brookfield has acquired a majority stake in Angel Oak, adding residential mortgage credit capabilities to Brookfield’s $332 billion credit platform. The partnership will accelerate Angel Oak’s growth while reinforcing Brookfield’s strategy of combining best-in-cl ...

Newport Beach, CA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Bimergen Energy Corporation [OTCQB: BESS], (“the Company” or “Bimergen”), a developer of utility-scale battery energy storage solutions and an independent power provider, today announced that it has secured the $50 million capital commitment to build out and add to their portfolio. Emergen Energy LLC, a wholly owned subsidiary of Bimergen, and our equity financing partner, a battery energy storage systems manufacturer have formed a joint venture that will ...

Strategic acquisition strengthens Parsons’ water capabilities across FloridaCHANTILLY, Va., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) today announced it has acquired Applied Sciences Consulting, Inc., a Florida-based engineering firm that specializes in water and stormwater solutions for cities, counties, and water management districts across the state. Founded in 2005, Applied Sciences is based in Tampa, Florida, and works closely with agencies across Florida to deliver solutions th ...

On July 14, Kaldalón announced the purchase of its own shares under a buyback program in week 28. The announcement stated that 2,544,345 of its own shares had been purchased at a purchase price of ISK 61,909,963, as further detailed in the announcement. Kaldalón received corrected information that in that week, Kaldalón purchased 2,549,537 own shares for ISK 62,035,609, as detailed below: Date Time Volume Price Purchae price Own shares post trans. 8.7.2025 10:28:10 635,000 24,2 15.367.000 ...

EAGLE, Idaho, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that on October 1, 2025, it acquired certain operations from UnitedHealth Group Incorporated (“UnitedHealth”). The operations were divested pursuant to UnitedHealth’s and Amedisys Inc.’s (“Amedisys”) antitrust settlement with the United States Justice Department. Pennant is purchasing diveste ...

Company transforms future-ready workspaces and simplifies work experiences with intelligent AI-powered solutionsNews Highlights: Announces 14 innovations to enhance workspaces, AI workflows, remote device support, and smart printing experiences.Introduces new ways to curate and maximize workspace with the latest displays and a dock that features proximity activation.Innovates AI development with the HP ZGX Nano G1n AI Station and new HP ZGX Toolkit.Empowers IT with new features, like Remote Connect, to sec ...

STAFFORD, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the expansion of FLAMINGO-01 clinical trial to Belgium. The Company's application to European regulators has been formally approved, adding Belgium as an approved country in FLAMINGO-01 in addition to S ...

Highlights: US Tariffs: Immuron does not anticipate any material impact from the recently announced US tariffs on pharmaceutical productsTravelan® Clinical Study: Topline results from the Travelan® clinical study conducted by Uniformed Services University are anticipated in October 2025 IMM-529 Regulatory Milestone: Immuron plans to submit an Investigational New Drug (IND) application to the U.S. FDA for IMM-529 (Clostridiodes difficile infection) in mid-October 2025ProIBS® Commercial Launch: The Australian ...